Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 05
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Fortress Biotech Inc
FBIO
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$2.03
-0.04
-1.93%
Ult. Agg.: Oct 2, 7:52 PM
$2.05
-0.02
-0.97%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Fortress Biotech Financials
Fortress Biotech (FBIO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Fortress Biotech Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $18.718M Beat $18.300M Estimate
Benzinga Newsdesk
PRO
Fortress Biotech Q1 EPS $2.82 Beats $(0.22) Estimate, Sales $16.038M Miss $16.338M Estimate
Fortress Biotech (NASDAQ:FBIO) reported quarterly earnings of $2.82 per share which beat the analyst consensus estimate of $(0.22) by 1381.82 percent. This is a 687.5 percent increase over losses of $(0.48) per share
Benzinga Newsdesk
PRO
Fortress Biotech Q4 EPS $(0.30) Beats $(0.42) Estimate, Sales $16.079M Miss $21.018M Estimate
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.42) by 28.57 percent. This is a 15.38 percent decrease over losses of $(0.26) per share from
Benzinga Newsdesk
PRO
Fortress Biotech Q3 EPS $0.11 Beats $(0.42) Estimate, Sales $17.631M Miss $21.018M Estimate
Fortress Biotech (NASDAQ:FBIO) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.42) by 126.19 percent. This is a 114.47 percent increase over losses of $(0.76) per share
Benzinga Newsdesk
PRO
CORRECTION: Fortress Biotech Q2 Adj. EPS $(0.46) Misses $(0.36) Estimate, Sales $16.413M Beat $14.534M Estimate
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.36) by 27.78 percent. This is a 36.99 percent increase over losses of $(0.73) per share
Benzinga Newsdesk
PRO
Fortress Biotech Q1 EPS $(0.48) Beats $(0.49) Estimate, Sales $13.14M Beat $11.62M Estimate
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.49) by 2.04 percent. This is a 53.85 percent increase over losses of $(1.04) per share from
Benzinga Newsdesk
